Kodiak Sciences
$3.30
24H
Market Cap
Volume
Supply
Price Chart
About Kodiak Sciences - KOD
Kodiak Sciences Inc. is a biopharmaceutical company focused on researching and developing innovative therapies for the treatment of retinal diseases. Their work often centers on using their proprietary antibody biopolymer conjugate technology, which is intended to enhance the durability of drug therapies and improve the treatment outcomes for patients.
What are Kodiak Sciences's core values and mission statement?
Kodiak Sciences Inc.'s core values include a commitment to patient care, innovation in retinal science, and integrity in its pursuit of developing transformative therapies. Their mission is to conquer chronic and prevalent retinal diseases through novel therapeutic strategies.
Who founded Kodiak Sciences and when?
Kodiak Sciences Inc. was founded by Victor Perlroth and Jason Ehrlich in 2009.
Who leads Kodiak Sciences?
As of the last update, Kodiak Sciences Inc. was led by Victor Perlroth, M.D., who is the CEO and co-founder of the company.
Where is Kodiak Sciences located, and what is its base country?
Kodiak Sciences Inc. is based in Palo Alto, California, in the United States.
On which exchanges is Kodiak Sciences traded?
Kodiak Sciences Inc. is traded on the Nasdaq Stock Market under the ticker symbol KOD.
Historical data
Kodiak Sciences (KOD) Price Live Data
The live price of Kodiak Sciences (KOD) is $3.30, with a trading volume of 213,610 in the last 24 hours. Wrapstocks updates the KOD price in real-time. Kodiak Sciences is up 3.45% in the last 24 hours. The company has a live market cap of $173,102,496.00 and a supply of 52,534,900 KOD stocks.
Kodiak Sciences (KOD) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 5 hours and 36 minutes.
